Metastatic Cancer First Unknown

Escozul™ is a natural product that has been shown to eliminate tumor cells, but this does not mean that it is a cure for cancer.

LifEscozul™ - Unknown Primary Metastatic Cancer

Its ability to inhibit malignant cell growth allows it to be used as a disease controller, and the focus of the work is on the patient's ability to live with his disease with the least possible impact on his daily routine. Since it is a product that presents other properties that we are still investigating, it does not have a commercial character, that is to say, Escozul™ is not sold. In order to enter the Protocol of use, the case must be analyzed to determine if Escozul™ will be of help to the patient. This step is vital and is free of charge.

It is important to note that Escozul™ is not considered a cure for cancer, it is a natural medicine that converts this deadly disease into a chronic controlled one, offering quality of life.

Results in different cases

Unknown primary metastatic cancer Patient: Irma Age: 66 Country: Uruguay.

She came to us in March 2016, through her daughter who was looking for a natural option to help her mother with a diagnosis of Metastatic Epidermoid Carcinoma.

Case summary:

Breast cancer.

Prognosis: Reserved to progression.

Patient:

Name: Irma

Age: 66 years old

Country: Uruguay

Summary

Our team received the medical documents of the case and the complementary report on Irma's physical condition. The analysis of the documentation showed that the patient had metastatic squamous cell carcinoma of the lung and liver, with multiple lymph node involvement in the neck, thorax and abdomen. Irma had presented a cervical cancer that was operated in 2010. Her blood parameters values were: GGT=295, FA=359, PCR=90.

In terms of symptoms Irma presented abdominal pain, loss of appetite, difficulty with digestion, interrupted rest, swelling and depression.

With these results, Irma's situation was explained to the family and a high dose was prescribed, to be increased progressively, looking for a positive response as far as possible according to the conditions of the case.

Irma started treatment with Escozul™ in April 2016. While she continues with chemotherapies.

Current results:

We received Irma's first report at the end of April 2016. After the first few weeks of administration the patient reported feeling well, with no pain or inflammation. Her blood parameters had started to decrease: GGT decreased to 124, FA=125, CRP= 23.4.

At the end of May 2016, studies showed a marked remission of mediastinal and retroperitoneal adenopathies as well as pulmonary nodules.

In August 2016, a contrast study was performed where a decrease in subcarinal adenomegalies was observed, with no significant changes in the number and size of pulmonary nodules. The rest of the examination showed no changes.

In the last report of September the blood parameters have decreased to normal values: GGT decreased to 38 being the normal value 39, PCR presents a value of 0.6.

According to this, the disease remains stable with a tendency to regression, which is a very positive result according to Irma's initial conditions and the short time she has been under treatment. Physically Irma is in very good condition. In the words of her daughter: "My mother is excellent, at first sight she has had a very remarkable evolution, she looks very well and has resumed her normal life, she does not even seem to be sick, looking at her from the outside she seems cured.

In spite of her diagnosis, the use of Escozul™ together with chemotherapy, has allowed Irma to control the disease, and she has been able to recover her hope and quality of life. We continue the Escozul™ treatment, with progressive doses, always seeking to improve these results.

As we always say, it is important to point out that it is not possible to generalize any result with Escozul™ to avoid creating false expectations in people, Escozul™ does not work miracles. Only working together and constant communication allow to keep the doses of Escozul™ personalized and functional against tumors.

It is also important to say that all the medical information of the case is available for consultation, as well as the contact with the medical counterpart of both the oncologist who attended the case and our specialists. We believe in transparency in dealing with our patients and the right to form an opinion based on information and analysis.

If you wish to be treated under the Escozul™ Protocol, please fill in the form on our website: www.escozul-cuba.com and one of our specialists will be at your disposal.

Prepared by LifEscozul™ Group.

Medical Documents

LifEscozul™ - Irma 1 - Cáncer Metastático Primario Desconocido
LifEscozul™ - Irma 1 - Cáncer Metastático Primario Desconocido
LifEscozul™ - Irma 1 - Cáncer Metastático Primario Desconocido
LifEscozul™ - Irma 1 - Cáncer Metastático Primario Desconocido
LifEscozul™ - Irma 1 - Cáncer Metastático Primario Desconocido
LifEscozul™ - Irma 1 - Cáncer Metastático Primario Desconocido
LifEscozul™ - Irma 1 - Cáncer Metastático Primario Desconocido

Brain metastasis of unknown primary tumor Patient: Danilo Age: 86 years old.

Patient with brain metastasis presents complete improvement of symptoms after 3 months of treatment with Escozul™ alone.

Case summary:

Whenever we publish a case we always look for cases with time in treatment. This week's case is different because the patient's improvement in such a short time has caught the attention of our specialists and physicians who have attended the case.

In October 2015 we received the case of Danilo, 86 years old, through his son who wrote to us concerned about the health of his father who had been diagnosed with the presence of 2 metastatic brain tumors (frontal inatraaxial and left occipital masses), with no evidence of primary tumor.

At that time Danilo was suffering from loss of appetite, unable to walk on his own due to loss of strength on the right side of his body, tremor in his hands, insomnia and intense dizziness. He had also presented with an episode of loss of consciousness, difficulty with speech and disorientation a few days earlier due to bleeding from the brain lesions and edema around the lesions. The oncologists reported that the situation was not at all encouraging and the prognosis was not good.

In evaluating the case, we agreed that the prognosis was poor and that the family should prepare for a near fatal outcome. We also informed them that Escozul™ could help improve their quality of life, although we were as conservative as possible to avoid false expectations. Nevertheless, the family decided to go ahead with Escozul™.

He began treatment with Escozul™ in October 2015. Also started physical therapy to help with movement as part of palliative care. The family decided not to proceed with chemotherapies and just treat him with Escozul™.

It is important to remember that Escozul™ is a natural product that has the ability to eliminate tumor cells, without meaning that it is a cure for cancer. Its capacity to inhibit malignant cell growth allows it to be used as a disease controller and the work focus is done so that the patient can live with his disease with the least possible effect on his daily routine.

Evolution, follow-up and current results:

In a case like Danilo's, the normal evolution of the patient goes in the direction of progressive neurological deterioration, worsening day by day his physical condition. We explained to the relatives from the beginning that it was very difficult to achieve an improvement in this case.

Danilo's relatives kept in touch since the first week of treatment, informing us about his physical condition. After 10 days they informed us that he had started to stand and walk with help, that he felt he had more strength. Dizziness and insomnia continued. He was also suffering from mood swings, anguish, irritability, which are typical of these initial moments in which the patient is coming to terms with the disease.

By the beginning of December, Danilo was stable, eating well, walking short distances supported by another person. Dizziness persisted.

In early January 2016, the family informs us that Danilo has fully recovered his appetite, is walking on his own, his dizziness is gone, he sleeps well, looks well, and there are no physical symptoms evidencing the disease.

A new MRI has not been done yet, the recommendation is to repeat it when completing the 6 months of treatment, to avoid subjecting him to more frequent studies and that he can lead a life as normal as possible.

In this case, the patient's current physical condition and his progressive improvement until the total disappearance of the neurological symptoms, point to an improvement in his disease, which was not expected in a case of brain metastasis without any conventional oncospecific treatment.

Danilo's recovery with Escozul™ has been impressive and infinitely superior to any expectations. We hope that during the next three months it will be maintained and can be reflected in the tests he will undergo. An important key has been the constant communication between the parties, always seeking to obtain the best possible results.

It is important to point out that it is not possible to generalize any result with Escozul™ to avoid creating false expectations in people. Each case we receive is analyzed in order to inform the family what to expect. Each person is a completely different universe, even if they have the same disease. This writing is not a testimony but a summary of evolution where medical information is available for consultation.

To know more about Escozul™, its effects and how to obtain it, please contact us at: servicios@lifescozulcuba.com

Medical Documents

LifEscozul™ - Danilo 1 - Cáncer Metastático Primario Desconocido
LifEscozul™ - Danilo 2 - Cáncer Metastático Primario Desconocido
LifEscozul™ - Danilo 3 - Cáncer Metastático Primario Desconocido
LifEscozul™ - Danilo 4 - Cáncer Metastático Primario Desconocido
LifEscozul™ - Danilo 5 - Cáncer Metastático Primario Desconocido
LifEscozul™ - Danilo 6 - Cáncer Metastático Primario Desconocido
LifEscozul™ - Danilo 7 - Cáncer Metastático Primario Desconocido
LifEscozul™ - Danilo 8 - Cáncer Metastático Primario Desconocido
LifEscozul™ - Danilo 9 - Cáncer Metastático Primario Desconocido
LifEscozul™ - Danilo 10 - Cáncer Metastático Primario Desconocido
LifEscozul™ - Danilo 11 - Cáncer Metastático Primario Desconocido
LifEscozul™ - Danilo 12 - Cáncer Metastático Primario Desconocido